beta-Hexosaminidase A (HEXA) + GM2 activator

Europe PMC · fetched just now · sorted by publication date

1. 1
   Seroprevalence of hepatitis E in blood donors in Santiago, Chile: a monocentric cross-sectional study.

   Porte L, Weitzel IB, Martínez-Valdebenito C, Pizarro G, Bustamante V, Weitzel T. · 2026-08-22

   open access unreviewed
2. 2
   Structural and functional characterisation of the dextran utilisome from <i>Bacteroides thetaiotaomicron</i>.

   Feasey M, Silale A, Baslé A, van den Berg B. · 2026-07-17

   cited 2× open access unreviewed
3. 3
   Exploring toothpaste ingredients as potential chemical kindling agents in neuropsychiatric disorders: An adult zebrafish (<i>Danio rerio</i>) study.

   Mathew T, Bhardwaj S, Goyal A, Bhatt A, Mahadevan A, Kashif MS, Karau PB, Mitra D, V V B, Pullikan J, Jose J,… · 2026-07-10

   open access unreviewed
4. 4
   Temperature-assisted stabilization of aqueous polychlorinated biphenyl stock solutions for sorption experiments.

   Števuľová R, Vadlamudi SK, Štibrányi L, Híveš J. · 2026-06-09

   open access unreviewed
5. 5
   Immunological insights into why pertussis continues to be endemic.

   Tanriover MD, Forsyth K, He Q, Diavatopoulos DA, Orozco Fernández R, Hozbor DF, Middleton DB, Muloiwa R, Muño… · 2026-06-30

   open access unreviewed
6. 6
   Early antibiotic exposure and vaccine immune responses in preterm infants: potential sex-specific differences.

   Haag L, Dietz-Ziegler S, Schwarz J, Kaiser G, Rühle J, Hebel J, Lesk T, Lajqi T, Müller J, Schoppmeier U, Fun… · 2026-06-27

   open access unreviewed
7. 7
   Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody.

   Bracke L, Gytz Olesen H, Pannecoucke E, Delahaye T, Persson EK, Blanchetot C, de Haard H, Hack CE, Andersen G… · 2026-05-04

   cited 1× open access unreviewed
8. 8
   Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network.

   Viñeta Paramo M, Kiely M, Valiquette L, Muller MP, McGeer A, Isenor JE, Sadarangani M, Kellner JD, Vanderkooi… · 2026-04-28

   cited 1× open access unreviewed
9. 9
   Long-term immune protection after infant hepatitis B vaccination in children.

   Tarigan Girsang R, Fadlyana E, Dwi Putra MG, Rusmil K, Setiabudiawan B, Kartasamita CB, Febfi T. · 2026-04-16

   open access unreviewed
10. 10
    Costs of managing adverse reactions to hexavalent vaccines: Comparison of DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib in France and Spain.

    Nikitas G, Mohy A, Duchenne M, Genovez V, Casabona G, Hennessy E, Vallejo L, Haddouche AA, Marijam A. · 2026-03-16

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.